Business Context and Reporting Period
This Form 8-K is filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc.) on August 3, 2021. The registrant is incorporated in Delaware and trades on the NYSE American under the symbol RMED. The report addresses the conclusion of a Securities and Exchange Commission (SEC) investigation.
Financial Metrics
This filing is a Current Report regarding a specific corporate event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. No financial metrics are provided in this document.
Material Changes
The material change reported is the resolution of a regulatory matter. The Company received a notice from the SEC stating that the agency has concluded its investigation and, based on available information, has decided not to recommend an enforcement action against the Company.
Guidance, Outlook, and Risks
- Management Commentary: The Company confirms the receipt of the SEC notice under the guidelines of Securities Act Release No. 5310.
- Risks and Contingencies: The primary risk previously associated with the ongoing SEC investigation has been resolved as of the date of the notice. No new risks or contingencies are disclosed in this filing.
- Guidance: No financial guidance or operational outlook is provided in this report.
Key Facts for Investor Verification
- Verify the Company name is Ra Medical Systems, Inc. (RMED), as the input metadata incorrectly referenced "Catheter Precision, Inc."
- Confirm the SEC investigation concluded without a recommendation for enforcement action as of August 3, 2021.
- Note that this filing contains no financial performance data; refer to the Form 10-Q for the period ended March 31, 2021, for prior financial context.